Cargando…

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations

The major risk factors for hepatocellular carcinomas (HCC) in high incidence areas include infection with hepatitis B and C viruses (HBV, HCV) and exposure to aflatoxin. Genetic alterations in 24 liver resection specimens from Shanghai and Qidong were studied. Hepatitis B virus was integrated in all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashid, A, Wang, J-S, Qian, G-S, Lu, B-X, Hamilton, S R, Groopman, J D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362990/ https://www.ncbi.nlm.nih.gov/pubmed/10389978 http://dx.doi.org/10.1038/sj.bjc.6690321

Ejemplares similares

Deletion mapping of chromosome 16q in hepatocellular carcinoma
por: Piao, Z, et al.
Publicado: (1999)

Reduced p21(WAF1/CIP1)protein expression is predominantly related to altered p53 in hepatocellular carcinomas
por: Shi, Y-Z, et al.
Publicado: (2000)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
por: Mihara, M, et al.
Publicado: (1999)

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001)

Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
por: Huiping, C, et al.
Publicado: (1999)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer
por: Harima, Y, et al.
Publicado: (1999)

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
por: Luttikhuis, M E M Oude, et al.
Publicado: (2001)

Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.
por: Schwendel, A., et al.
Publicado: (1998)

The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations
por: Boyle, J M, et al.
Publicado: (2001)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3
por: Cleton-Jansen, A-M, et al.
Publicado: (1999)

Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000)

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
por: Tavassoli, M., et al.
Publicado: (1996)

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999)

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
por: Saffroy, R, et al.
Publicado: (1999)

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type
por: Vos, C B J, et al.
Publicado: (1999)

Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma
por: Lee, A S-G, et al.
Publicado: (2000)

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1–q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient
por: Elo, J P, et al.
Publicado: (1999)

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
por: Ragnarsson, G, et al.
Publicado: (1999)

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma
por: Hu, Y-X, et al.
Publicado: (1999)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours
por: Hu, J, et al.
Publicado: (2002)

P53 germline mutations in childhood cancers and cancer risk for carrier individuals
por: Chompret, A, et al.
Publicado: (2000)

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
por: Veldhoen, N, et al.
Publicado: (1999)

Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer
por: Wu, X, et al.
Publicado: (1999)

The expression of p73 is increased in lung cancer, independent of p53 gene alteration
por: Tokuchi, Y, et al.
Publicado: (1999)

PTEN/MMAC1 Mutation and Frequent Loss of Heterozygosity Identified in Chromosome 10q in a Subset of Hepatocellular Carcinomas
por: Fujiwara, Yoshiyuki, et al.
Publicado: (2000)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss
por: Hoshi, M, et al.
Publicado: (2000)

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
por: Edwards, J, et al.
Publicado: (2001)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

p53 Gene Mutation and Loss of Heterozygosity of Chromosome 11 in Methylcholanthrene‐induced Mouse Sarcomas
por: Shimokado, Kiyoshi, et al.
Publicado: (1998)

Chromosome band 16q24 is frequently deleted in human gastric cancer
por: Mori, Y, et al.
Publicado: (1999)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_qj7l8bg5l9kqrrbosao6caods8